Yeju Medical: The first patient has been enrolled in a clinical trial in Japan for the drug-coated balloon catheter developed independently.

In a medical announcement, Yejuy Medical stated that the first patient has been enrolled in a crucial clinical trial conducted in Japan. This trial will evaluate the group's independently developed coronary artery paclitaxel drug-coated balloon, marking an important step in solidifying the group's leading position in the interventional cardiology market in Japan with a diverse product portfolio.